ADO 0.00% 2.1¢ anteotech ltd

Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-182

 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.